This page includes the latest FDA filings for Lonza Biologics Tuas Pte L T D. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Mesoblast, Mesoblast, Inc., LONZA BIOLOGICS TUAS PTE. LTD., Integrated Commercialization Solutions, LLC, WuXi Advanced Therapies Inc. | Prescription Medication | 2025-01-01 |
argenx US, Patheon Italia SpA, Lonza Biologics Tuas Pte.Ltd., Avid Bioservices Inc., Catalent Indiana, LLC | Prescription Medication | 2024-08-23 |
argenx US, Patheon Italia SpA, Lonza Biologics Tuas Pte.Ltd., Avid Bioservices Inc., Catalent Indiana, LLC | Prescription Medication | 2024-06-28 |
argenx US, Patheon Italia SpA, Lonza Biologics Tuas Pte.Ltd., Avid Bioservices Inc., Catalent Indiana, LLC | Prescription Medication | 2024-02-14 |
argenx US, Patheon Italia SpA, Lonza Biologics Tuas Pte.Ltd., Avid Bioservices Inc., Catalent Indiana, LLC | Prescription Medication | 2023-12-19 |
argenx US, Patheon Italia SpA, Lonza Biologics Tuas Pte.Ltd., Avid Bioservices Inc., Catalent Indiana, LLC | Prescription Medication | 2023-06-25 |
Lonza Biologics Tuas Pte Ltd. | 2018-11-21 | |
Lonza Biologics Tuas Pte Ltd. | 2018-11-06 | |
Lonza Biologics Tuas Pte Ltd. | 2017-12-01 | |
Lonza Biologics Tuas Pte Ltd. | 2007-04-01 |